Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
FOR RESEARCH PURPOSES ONLY This product is intended for research and laboratory use only
MOTS-c and exercise-induced physical decline Reynolds JC et al
10.1016/j.neuropharm.2015.01.028 77
b) National Research Council project Nutrizione, Alimentazione ed Invecchiamento attivo (NUTRAGE) (FOE 2021-2022) to AS
Original research articles (in vitro, in vivo, human observational and clinical trials) in which cardiovascular, renal and metabolic influences from GLP-1RA were the primary outcomes were included
Chronic daily administration of an amylin receptor or GLP-1R analog as a mono- or combinatorial-therapy on body weight gain and food intake Experiments were designed to determine whether chronic combinatorial administration of an amylin receptor agonist with a GLP-1R agonist is superior in producing a greater magnitude of sustained weight loss and food intake suppression compared to monotherapy in a diet induced obese rat model
US$ 24.95
US$ 29.29
US$ 26.18
US$ 21.82
US$ 23.00
